News + Filings Holdings
|
BAILLIE GIFFORD & CO
> ALNY
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 8,392,216 | -1,015,655 | 1,594,017,507,000 | -641,763,037,000 | $189,940.00 |
12/31/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 9,407,871 | -560,563 | 2,235,780,544,000 | 2,234,326,648,000 | $237,650.00 |
06/30/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 9,968,434 | -171,295 | 1,453,896,000 | -201,820,000 | $145.85 |
03/31/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 10,139,729 | -477,022 | 1,655,716,000 | -144,672,000 | $163.29 |
12/31/2021 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 10,616,751 | 200,967 | 1,800,388,000 | -166,217,000 | $169.58 |
09/30/2021 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 10,415,784 | 190,925 | 1,966,605,000 | 233,286,000 | $188.81 |
06/30/2021 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 10,224,859 | 149,896 | 1,733,319,000 | 310,835,000 | $169.52 |
03/31/2021 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 10,074,963 | 942,541 | 1,422,484,000 | 235,543,000 | $141.19 |
12/31/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 9,132,422 | 240,934 | 1,186,941,000 | -107,659,000 | $129.97 |
09/30/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 8,891,488 | 242,810 | 1,294,600,000 | 13,644,000 | $145.60 |
06/30/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 8,648,678 | 236,909 | 1,280,956,000 | 365,335,000 | $148.11 |
03/31/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 8,411,769 | 225,046 | 915,621,000 | -27,244,000 | $108.85 |
12/31/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 8,186,723 | -49,251 | 942,865,000 | 280,529,000 | $115.17 |
09/30/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 8,235,974 | 2,022,504 | 662,336,000 | 211,486,000 | $80.42 |
06/30/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 6,213,470 | 528,966 | 450,850,000 | -80,367,000 | $72.56 |
03/31/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 5,684,504 | 937,654 | 531,217,000 | 185,124,000 | $93.45 |
12/31/2018 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 4,746,850 | 284,024 | 346,093,000 | -44,494,000 | $72.91 |
09/30/2018 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 4,462,826 | 230,945 | 390,587,000 | -26,211,000 | $87.52 |
06/30/2018 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 4,231,881 | 397,668 | 416,798,000 | -39,858,000 | $98.49 |
03/31/2018 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 3,834,213 | 223,199 | 456,656,000 | -2,123,000 | $119.10 |
12/31/2017 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 3,611,014 | 205,622 | 458,779,000 | 58,680,000 | $127.05 |
09/30/2017 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 3,405,392 | -25,924 | 400,099,000 | 126,418,000 | $117.49 |
06/30/2017 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 3,431,316 | 96,805 | 273,681,000 | 102,787,000 | $79.76 |
03/31/2017 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 3,334,511 | 16,489 | 170,894,000 | 46,667,000 | $51.25 |
12/31/2016 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 3,318,022 | -50,303 | 124,227,000 | -104,078,000 | $37.44 |
09/30/2016 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 3,368,325 | 3,368,325 | 228,305,000 | 228,305,000 | $67.78 |
06/30/2016 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 3,390,252 | 10,317 | 188,125,000 | -24,034,000 | $55.49 |
03/31/2016 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 3,379,935 | 2,670,685 | 212,159,000 | 155,164,000 | $62.77 |
12/31/2015 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 2,727,734 | 2,018,484 | 256,790,000 | 199,795,000 | $94.14 |
09/30/2015 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 709,250 | -82,500 | 56,995,000 | -37,912,000 | $80.36 |
06/30/2015 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 791,750 | -231,680 | 94,907,000 | -11,959,000 | $119.87 |
03/31/2015 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 1,023,430 | -70,000 | 106,866,000 | 804,000 | $104.42 |
12/31/2014 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 1,093,430 | 1,093,430 | 106,062,000 | 106,062,000 | $97.00 |
09/30/2014 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 1,190,930 | 1,190,930 | 93,011,000 | 93,011,000 | $78.10 |
06/30/2014 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | 1,190,930 | 1,190,930 | 75,231,000 | 75,231,000 | $63.17 |
<< Prev Next >> |
|